FDA approves Journavx for moderate to severe acute pain
Journavx is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than 20 years.
Journavx is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than 20 years.
With over 20 years in consumer goods and beauty, Christina Fair brings extensive expertise to her new role.
As the countdown to the Big Game begins, snack lovers can anticipate a commercial that is as memorable as the iconic Pringles crunch.
New leadership position focuses on driving innovation, growth and service excellence.
The selection is based on nine key attributes related to corporate reputation, including quality of products and services, innovation, community responsibility, social responsibility, and talent management.
The list is compiled of the 650 highest-revenue companies from 51 industries across 30 countries.
Clinical trials showed Ozempic slowed kidney disease progression and lowered risks of kidney failure and cardiovascular events.
Company raises fiscal year 2025 outlook.
“The new sleek cans and bold designs highlight a reinvented brand expected to appeal to new consumers seeking delicious and refreshing fruit flavor combinations to enjoy wherever their escape takes them.”
Sirolimus oral solution is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in patients aged greater or equal to 13 years, receiving renal transplants.
Blended, patient-level datasets leveraging proprietary tokenization technology simplify data enrichment while adhering to privacy standards.
Mars brand launches the Second Screen Staredown to bring two times the fun to fans during the Big Game.
The fastest-growing beer in the U.S returns to the Super Bowl with megawatt talent including Willem Dafoe, Catherine O'Hara, Randy Moss, Sabrina Ionescu and Ryan Crouser.
Study participants experienced improved joint comfort and mobility after taking 100 mg of Boswellia serrata extract for 6 months.
"We’re thrilled to help brands find their next production partner quickly and with far less stress.”
The latest Chips Ahoy! innovation is an upgrade on the brand’s chocolate chip cookie, with a soft and chewy texture inspired by brownies.